Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.4201 | 13.6396103896 | 3.08 | 3.52 | 3.06 | 158886 | 3.36607077 | CS |
4 | -0.0299 | -0.847025495751 | 3.53 | 4.1499 | 2.99 | 308665 | 3.43326915 | CS |
12 | -43.6999 | -92.5845338983 | 47.2 | 51.2569 | 2.99 | 390575 | 8.45960433 | CS |
26 | -29.9899 | -89.5488205434 | 33.49 | 53.79 | 2.99 | 228573 | 17.56316257 | CS |
52 | -12.7399 | -78.4476600985 | 16.24 | 53.79 | 2.99 | 163772 | 18.37017476 | CS |
156 | -12.7399 | -78.4476600985 | 16.24 | 53.79 | 2.99 | 163772 | 18.37017476 | CS |
260 | -12.7399 | -78.4476600985 | 16.24 | 53.79 | 2.99 | 163772 | 18.37017476 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.